Cencora Reaffirms Guidance After Limited Walgreens Volume Shift

Cencora reaffirms $17.75–$17.95 FY2026 EPS after minor Walgreens volume shift. Analysts see just 3–3.5% impact as core prime vendor deal stays intact.